News | September 01, 2022
Merck India inaugurates R&D Excellence Centre in Bangalore
The Centre aims at promoting innovation among the scientific community to improve healthcare solutions around the globe
The Centre aims at promoting innovation among the scientific community to improve healthcare solutions around the globe
The Phase IV DREAM-CKD trial will enrol 1004 CKD patients in India, including 502 dialysis dependent, 502 dialysis independent CKD patients with anemia.
New mass spectrometry instrument and consumables launch during IMSC 2022
To mark the occasion, Integrated Pharmaceutical Database Management System 2.0 (IPDMS 2.0), an integrated responsive cloud-based application developed by NPPA with technical support from C-DAC will be launched
The unit has filed 2 Derma products and 1 MDI product.
There are no data integrity (DI) observations.
Pending authorization, Moderna ready to ship bivalent booster mRNA-1273.222 in September
A special purpose vehicle (SPV) formed by O2 Energy SG Pte Ltd, for generation and supply of renewable power
The company has received 1 (ONE) observation on Form 483 with respect to ANDA filed for the product to be manufactured at the said Facility.
99% of Pristyn Doctors are using EMR facility on its doctor app
Subscribe To Our Newsletter & Stay Updated
